Does clinical trial participation improve outcomes in patients with ovarian cancer? - Wikidata - awgldk - TriplyDB

Does clinical trial participation improve outcomes in patients with ovarian cancer?

Does clinical trial participation improve outcomes in patients with ovarian cancer?

http://www.wikidata.org/entity/Q54912094

about

Does clinical trial participation improve outcomes in patients with ovarian cancer?

http://www.wikidata.org/entity/Q54912094

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Does clinical trial participation improve outcomes in patients with ovarian cancer?

@en

Does clinical trial participation improve outcomes in patients with ovarian cancer?

@nl

type

label

Does clinical trial participation improve outcomes in patients with ovarian cancer?

@en

Does clinical trial participation improve outcomes in patients with ovarian cancer?

@nl

prefLabel

Does clinical trial participation improve outcomes in patients with ovarian cancer?

@en

Does clinical trial participation improve outcomes in patients with ovarian cancer?

@nl

P1433

Q54912094-D2094FCF-A877-45B1-8555-0041F1476F1D

P1476

Q54912094-7261AD78-E85C-449A-AB9C-CF1DAADC5D84

P2093

Q54912094-39288F3B-D847-4B0F-8071-1596E4BCF318

Q54912094-3CC05912-3C88-4AFE-B3F5-C28FCAAC2E2E

Q54912094-724725A8-5C2B-4FC6-8DF2-D52F20311CFF

Q54912094-9A9C1797-8D58-40B1-BF41-F819FCE57DDF

Q54912094-A86C6F1B-5D4B-48F1-80A3-5525C7CBF3E1

Q54912094-AF742566-7083-47F2-91C9-D032A2DF61E8

Q54912094-E149D1E4-249D-4E69-8961-A2343E4D3786

P2860

Q54912094-04C18748-6E62-4946-B3C0-F6EF40FC06CB

Q54912094-0A057828-E9CA-475F-B7C5-1CA366795539

Q54912094-0FC233FA-E94A-4E66-836A-1986A96E8F22

Q54912094-13039CC9-5279-4710-9ABE-F5DBAD40B779

Q54912094-4BC87697-0F2F-4480-9E54-F7E6A3DED33A

Q54912094-866424C7-E6D0-4698-9CCC-F499B4840D40

Q54912094-971E99E3-F4C4-4BF4-9E65-C5B5624650C0

Q54912094-A26B8A8F-1205-4F2C-85EA-CE592CD3126F

Q54912094-B41E06C6-E7E5-4D5C-8AB1-1B3A52E4EB56

Q54912094-C9FF719D-4F0C-47AA-B3EB-9F060F90C8E5

P304

Q54912094-CC52C2F0-05EF-4A2C-9EF9-BBED46495976

P31

Q54912094-E439BC16-DC24-4716-9C38-3788A880FA2B

P356

Q54912094-868794C0-A5A4-4BF9-B11E-B40CA63A252A

P433

Q54912094-BD18767D-5634-4308-9960-3EC11C1AEC86

P478

Q54912094-F7136936-2BC6-4886-9F9D-E42D7AB21EBD

P50

Q54912094-CD5A365E-FF79-4EEE-BA74-B07B71793B55

P577

Q54912094-AB4FCF72-4645-45DD-A544-770225181AC2

P698

Q54912094-D11303DE-DCDE-4976-B473-26E87B450101

P921

Q54912094-1F3E9AA5-B302-4819-BF86-BD95E6494BAA

P932

Q54912094-4A2AB774-8015-4F2F-A657-80EF0427CDAA

P356

ESMOOPEN-2016-000057

P1433

P1476

Does clinical trial participation improve outcomes in patients with ovarian cancer?

@en

P2093

A Heesters

http://www.w3.org/2001/XMLSchema#string

A R Clamp

http://www.w3.org/2001/XMLSchema#string

C Mitchell

http://www.w3.org/2001/XMLSchema#string

J D Machin

http://www.w3.org/2001/XMLSchema#string

J Hasan

http://www.w3.org/2001/XMLSchema#string

L Horsley

http://www.w3.org/2001/XMLSchema#string

L Khoja

http://www.w3.org/2001/XMLSchema#string

P2860

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.

Systematic review to determine whether participation in a trial influences outcome

A phase 3 trial of bevacizumab in ovarian cancer.

The therapeutic misconception: informed consent in psychiatric research.

Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review.

A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG

P304

e000057

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ESMOOPEN-2016-000057

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Gordon C. Jayson

P577

2016-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27843621

http://www.w3.org/2001/XMLSchema#string

P921

P932

5070238

http://www.w3.org/2001/XMLSchema#string